Opthea Ltd SEC filings CYVNY

Opthea Ltd has 204 filings in SEC EDGAR's recent list, going back to Jul 17, 2020. Its latest annual report, Form 20-F, was filed on Sep 15, 2025 for the period ended Jun 30, 2025. The most recent current report (Form 6-K) was filed on Nov 20, 2025. The company's fiscal year ends on June 30.

Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 7, 2026 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 3, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 15, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2022 —
SC 13G Ownership over 5% (passive) Feb 16, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 10, 2021 —
SC 13G Ownership over 5% (passive) Nov 12, 2020 —

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CKDXF (OTC), CYVNY (OTC)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
South Yarra
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1815620

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.